HMOX1 and chronic kidney disease: The study of Awadalla [98] indicated that intraperitoneal injection of ZnO-NPs (5 mg/kg, 3 times/week, for 8 weeks) up-regulated antioxidant genes (Nrf2 and HO-1) in the induced-chronic kidney disease rats.